Feed LNSR
LN

LENSAR, Inc.

LNSR · NASDAQ

$7.25 -0.68% (-$0.05)
1M -21.45%
Market Cap $89.0M
P/E Ratio 2.57x
Div. Yield -
ROE -
Piotroski F-Score Moderate
5/9
Valuation
87 /100
Cheap
P/E 2.57x
EV/EBITDA 2.19x
P/B 5.97x
Growth
100 /100
Growing
Rev. growth 18.23%
EPS growth N/A
FCF growth N/A
Profitability
39 /100
Moderate
Gross margin 47.96%
Net margin 57.57%
FCF margin 12.16%
Quality
37 /100
Average
ROIC 22.01%
ROA 49.88%
Asset turnover 0.87x
Debt
100 /100
Low
Debt/Equity 0.16x
Current ratio 2.39x
Net debt/EBITDA -0.31x
Stability
55 /100
Moderate
Beta 0.97x
Rev. volatility 8.84%
Profitable years 0

Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več

Vprašajte StockBota o LNSR
Online

O podjetju

LENSAR, Inc. (LSR) is an American company focused on the development and manufacturing of advanced technologies for surgical ophthalmology. With a product portfolio including innovative surgical systems like the LENSAR® Laser System, LENSAR provides state-of-the-art solutions for cataract procedures. Their technology combines advanced robotics, 3D imaging, and laser energy, enabling precise and personalized surgical interventions for patients. LENSAR, Inc. also emphasizes continuous development and innovation in the field of ophthalmic surgery. Shares of LENSAR, Inc. (LSR) could be suitable for investors seeking opportunities in the healthcare technology sector with a focus on ophthalmic surgery and innovative technologies.

V vašem jeziku še ni na voljo, zato je besedilo v angleščini.

Sector

Healthcare

Industry

Medical - Devices

CEO

Nicholas T. Curtis

Employees

150

Headquarters

Orlando

Prihajajoči dogodki

12 NOV.

Earnings

Upcoming earnings report

50d

Uporabljamo nujne piškotke za delovanje spletnega mesta in izbirne analitične piškotke za merjenje uporabe. Preberite naš Pravilnik o zasebnosti.